Abstract
We describe radiographic, contrast-enhanced MDCT and MRI findings with pathologic correlations of an unusual recurrence of tumoral calcinosis, also called Teutschlander disease. The disease was silent in the first decade of life, when it appeared with elbows recurring lesions, until the seventh decade of life, when a left hip active growth lesion developed. A review about tumoral calcinosis pathogenesis, clinical course and imaging differential diagnosis is reported. (www.actabiomedica.it)
Keywords: calcifications; tumoral calcinosis, Teutschlander disease, musculo-skeletal (MSK) imaging, magnetic resonance imaging
Introduction
Tumoral calcinosis (TC), also called Teutschlander disease, is a relative rare disorder characterized by calcium salts accumulation in iuxta-articular soft-tissues, producing solitary or multiple painless periarticular masses (1, 2). Large joints such as the hip, shoulder, and elbow are usually involved. This entity most commonly presents in the first 2 decades of life. Approximately one-third of patients with TC shows familial inheritance (3, 4).
TC has been generally presented as case reports and the plain radiography findings of the disease have been well documented. To date, there are few studies presenting computed tomography (CT) and magnetic resonance (MR) imaging characteristics of TC with radio-pathologic correlation (5).
We report the unusual case of an adult patient without familiar inheritance, who had undergone surgery for elbows TC during the first decade of life and presented left hip recurrence in the sixth decade. We describe CT and MR findings with histopatological correlation on surgical specimen.
Case report
A 64 years-old male patient was referred to our institution for swelling of the left gluteus and hip. He had a history of elbow recurring TC in the first decade of life that needed five surgical procedures. No other manifestations of calcinosis occurred during the following decades. He didn’t referred TC in the other family members.
The patient had a mild hyperphosphatemia, without haematic value alterations of 1,25-dihydroxyvitamin D or parathyroid hormone. Renal function was normal.
Radiography showed a grossly periarticular calcified mass around the left hip joint and the upper thigh (Fig. 1). At contrast-enhanced (CE) multidetector computed-tomography (MDCT) a grossly calcified lobular mass was visible with large cystic areas and fluid-fluid levels inside (CT sedimentation sign) (Fig. 2a and 2b). A peripheral enhancement of cystic areas was observed after CE administration, without pathologic solid portions. The mass was localized in the region of the left greater trochanteric bursa, deeply to gluteal muscles, extending medially to the upper part of the ischio-pubic branch, and along the posterior compartment of the lower part of the thigh, as well demonstrated by CT multiplanar and tridimensional (3D) images (Fig. 3a-c).
Figure 1.
Radiography shows a grossly periarticular calcified mass around the left hip joint and the upper thigh
Figure 2.
On MDCT, reported in soft-tisse (a) and bone (b) windows, the mass has large cystic areas, with gross and egg-shell calcifications and fluid-fluid levels inside (“sedimentation sign”)
Figure 3.
MPR reconstructions on coronal (a) and sagittal (b) planes and 3D reconstructions (c) CT scans better depict lesion localization and extension around the left hip joint and the upper thigh
At MRI the lesion had inhomogeneous diffuse low signal intensity on T1-weighted sequences, while it presented alternating signal patterns on T2-weighted sequences with low intensity areas and cystic components with fluid-fluid levels (MRI sedimentation sign) (Fig. 4a-f). After CE administration, fibrous septa surrounding cystic and calcified areas enhanced, producing a “web” or “cobblestone” pattern. No nodular enhancement was reported, neither involvement of surrounding muscolar and bone structures, vessels and nerves.
Figure 4.
On MRI axial T2w (a) and fat-suppressed T2w (b) sequences the lesion present low intensity and bright nodular areas, with cystic components and fluid-fluid levels (“sedimentation sign”). On T1w sequences (c) lesion shows inhomogeneous diffuse low signal intensity. After CE injection, T1w axial, coronal and sagittal images show (d, e and f) fibrous septa surrounding cystic and calcified areas enhanced, producing a “web” or “cobblestone” pattern.
Patient underwent surgery. The mass was resected, measuring 62 cm in the largest diameter. Pathologic evaluation confirmed the diagnosis of TC, showing grossly calcifications and cysts with chalky material inside (precipitated calcium salt), surrounded by inflammatory reaction and fibrosis (Fig. 5a-c). No signs of malignancy were found and no part of the mass was seen to make direct contact with the underlying bone.
Figure 5.
(a) The cut surface of the surgical specimen was yellow-white with a cystic appearance. (b, c) Low-power photomicrographs show calcific debris with chronic inflammatory reaction and surrounding fibrosis.
Discussion
TC was first described by Giard (7) and Duret (8) in 1898 and 1899 and then widely studied from 1930 to 1950 by a german pathologist, Otto Teutschlander and named it as “lipocalcinogranulomatosis” (9). The current term of TC was firstly used by Inclan in 1943 in American literature (10). During the following years the disease has been identified with different terms and criteria. To date, approximately 200 cases have been reported since Duret’s first description in 1899 (11-14).
Pathogenesis of TC is not known, and similar lesions can be observed in metabolic disease with increased haematic levels of calcium and phosphate, such as chronic renal failure, primary hyperparathyroidism, hypervitaminosis D, sarcoidosis (15, 16). On the basis of 122 reviewing cases and their clinical and pathologic findings, Smack et al divided all TC in three groups (17). One group are primary normo-phosphatemic TC usually presenting in first two decades of life as solitary lesions. According to this group of authors these patients are without evident familial connection, although recent literature detected familial connection involving mutations in the gene encoding SAMD9 protein. The second group are primary hyperphosphatemic TC usually presenting during the first and second decades of life. This group of patients have genetic predisposition with reduced urinary phosphate excretion caused by recessive mutations in GALNT3 and KLOTHO, that causes the inactivation of FGF23, a phosphaturic hormone. The third group encompasses secondary TC connected with chronic renal failure. Despite their different etiology and pathogenesis, histopathology is identical in all types suggesting possible common path-way which eventually results in the formation of the characteristic TC lesions and originates from minimal repetitive trauma and reparative inflammatory process (17-20).
Typical radiological findings in TC suggest a correct diagnosis in the majority of cases. Radiographs show lobulated calcifications on joints extensor surface. Calcifications are well defined, rounded, sometimes with a cystic appeareance and a fluid-fluid level inside (14). Fluid-fluid levels, producing the “sedimentation sign”, derive by calcium crystals layering inside intracystic amorphous chalky material. Fibrous septa can produce linear or curved radiolucencies between gross calcifications, producing a “cobblestone” pattern (12).
CT shows calcified cystic lesions in fibrofatty planes, deeply to muscles. It clearly depicts lesion topography and extension, particularly using 2D Multiplanar Reconstruction (MPR), 3D Shaded Surface Display (SSD) and Volume Rendering (VR) reconstruction. Reconstructions help surgeons to correctly plan a complete surgical ablation (1).
At MRI lesions have variable signal intensity, with a low signal in largely calcified portions, and cystic areas with high signal in T2-weighted sequences. At MRI the typical “sedimentation sign” shows a greater conspicuity (5). According to some authors (1), an alternating high and absent signal MRI pattern is associated to metabolically active lesions, with a prominent fluid/inflammatory component. After contrast injection, only a mild contrast enhancement of fibrous septa can be observed (21).
Some authors have documented an ultrasonographic (US) approach to TC (22, 23). In acute cases, in which a mass is initially forming or beginning to enlarge and vascular signals are more detectable, TC may present as a well-circumscribed homogenous mass with an irregular border of calcifications. In chronic cases, which tend to be defined by more cystic changes and fibrous septa, US may reveal a lobulated cystic echogenic mass with septa and a calcified rim. The sedimentation sign may also be observed (22-26). However, the cystic appearance on US is aspecific since it may easily mimic as an abscess formation (27, 28).
Also the value of angiography in evaluating soft tissue calcific masses has been reported (29-33). Benign soft tissue masses do not typically change the normal vessel diameter, nor do they demonstrate neovascularity, blush, pooling, encasement, arteriovenous shunts or feeding vessels (34, 35). Angiography of benign soft tissue masses typically shows displaced or stretched vessels (36). TC is atypical for benign soft tissue masses in that it is a relatively vascular process. In a radio-pathologic correlation study (37), TC has been proven to be hypervascular during the active phase, similarly to myositis ossificans. Specifically, the active stage of tumoral calcinosis has fluid with sedimentation or calcific foci at the edges, cellular pleomorphism and a prominent vascular component (36, 37).
This active and hypervascular stage could take advantage of an early surgery (29). In this setting, some authors have proposed a vascular study of TC lesions by contrast-enhanced ultrasound (CEUS), which is a “new” simple, immediate, and effective US tool: microbubbles circulate freely inside the body and constitute an intravascular contrast agent (38, 39); therefore, they permit analysis of both macro- and microvascular lesional blood flow (40, 41). The technique yields information about contrast enhancement almost as CT (42, 43) and MRI (44, 45) do but in real time and without the use of ionizing radiation. To date, CEUS has obtained valid results in different areas (38-41), although the method has not yet entered in standardized vascular imaging protocols for clinical practice.
Differential diagnosis includes many conditions with similar periarticular soft tissues calcifications. Grossly periarticular soft-tissues calcifications can be observed in connective tissue diseases (polymyositis, dermatomyositis, lupus erythematosus) or traumatic/degenerative diseases (synovial osteochondromatosis, calcific tendonitis, myositis ossificans, calcific myonecrosis). Clinical history, joint involvement and morphology and distribution of calcifications usually allow a correct differential diagnosis (46, 47). Differential diagnosis with malignant neoplasms is critical, particularly with synovial sarcoma, parosteal osteosarcoma and chondrosarcoma. Synovial sarcoma usually develops in periarticular regions as an inhomogeneous infiltrative mass only partially occupied by grossly calcified areas inside (48). Parosteal osteosarcoma and chondrosarcoma arise from bone surface extending in surrounding soft tissues as a densely calcified mass. Radiographic appeareance may suggest TC when bone don’t show significant anomalies. Cross-sectional imaging accurately depicts sarcomatous malignant infiltrative growth toward underlying bone and surrounding structures and a high enhancing tissutal portion after CE inside the mass or around calcified components (1).
In the case presented the lesion had typical radiological features of TC. The mass was localized at the extensor surface of hip joint, with a benign expansive growth. It was largely occupied by calcifications and cystic areas with fluid-fluid levels inside (“sedimentation sign”); no nodular enhancing areas were evident. MRI also showed an inhomogeneous high signal intensity in T2-weighted sequences, although these features have been more frequently reported in younger patients with metabolically active lesions (1). Moreover, the disease showed an unusual course: after a typical onset in the first decade of life, disease had been silent until the sixth decade, when it recurred with a left hip active growth lesion.
Surgical excision is a well documented treatment, but recurrences after surgery due to poor circumscription are common, particularly in metabolically active lesions (5). Recurrences can also occur several years after intervention (49). Until now, however, only few reports in literature have described MRI findings in TC recurrences (5).
To conclude, TC can occur with different clinical and biochemical patterns. We report an unusual relapse with a metabolically active lesion in an adult man after a long period of quiescence. Differential diagnosis can be difficult in unusual clinical settings, but a careful evaluation of imaging findings and biochemical data can suggest the correct diagnosis.
Conflict of interest:
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article
References
- 1.Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 2006;26:871–85. doi: 10.1148/rg.263055099. [DOI] [PubMed] [Google Scholar]
- 2.Steinbach LS, Johnston JO, Tepper EF, Honda GD, Martel W. Tumoral calcinosis: radiologic-pathologic correlation. Skeletal Radiol. 1995;24:573–8. doi: 10.1007/BF00204854. [DOI] [PubMed] [Google Scholar]
- 3.Hammert WC, Lindsay LR. Tumoral Calcinosis – or is it? A Case Report and Review. Hand (NY) 2009;4:119–122. doi: 10.1007/s11552-008-9132-0. doi: 10.1007/s11552-008-9132-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Viegas SF, Evans EB, Calhoun J, Goodwiller SE. Tumoral calcinosis: a case report and review of the literature. J Hand Surg. 1985;10:744–748. doi: 10.1016/s0363-5023(85)80225-2. [DOI] [PubMed] [Google Scholar]
- 5.Senol U, Karaal K, Cevikol C, Dincer A. MR imaging findings of recurrent tumoral calcinosis. Clin Imaging. 2000;24:154–6. doi: 10.1016/s0899-7071(00)00190-x. [DOI] [PubMed] [Google Scholar]
- 6.Smeets HG, Lamers RJ, Sastrowijoto SH. Tumoral calcinosis. AJR Am J Roentgenol. 1996;167:818–9. doi: 10.2214/ajr.167.3.8751711. [DOI] [PubMed] [Google Scholar]
- 7.Giard A. Sur la calcification hibernale. C R Soc Biol. 1898;10:1013–1015. [Google Scholar]
- 8.Duret MH. Tumours multiples et singulieres des bourses sereuses (endotheliomes, peutetre d’origine parasitaire) Bull Mem Soc Anat Paris. 1899;74:725–733. [Google Scholar]
- 9.Teutschlaender O. Die lipoido-calcinosis oder lipoidkalkgicht. Beitr Pathol Ana. 1949;110:402–432. [Google Scholar]
- 10.Inclan A, Leon P, Camejo MG. Tumoral calcinosis. J Am Med Assoc. 1943;121:490–495. [Google Scholar]
- 11.Sledz K, Ortiz O, Wax M, Bouquot J. Tumoral calcinosis of the temporomandibular joint: CT and MR findings. AJNR Am J Neuroradiol. 1995;16:782–5. [PMC free article] [PubMed] [Google Scholar]
- 12.Fathi I, Sakr M. Review of tumoral calcinosis: A rare clinico-pathological entity. World J Clin Cases. 2014;2:409–14. doi: 10.12998/wjcc.v2.i9.409. doi: 10.12998/wjcc.v2.i9.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sprecher E. Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J Invest Dermatol. 2010;130:652–660. doi: 10.1038/jid.2009.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Martinez S, Vogler JB, 3rd, Harrelson JM, Lyles KW. Imaging of tumoral calcinosis: new observations. Radiology. 1990;174:215–222. doi: 10.1148/radiology.174.1.2294551. [DOI] [PubMed] [Google Scholar]
- 15.Franco M, Van Elslande L, Passeron C, Verdier JF, Barrillon D, Cassuto-Viguier E, et al. Tumoral calcinosis in hemodialysis patients: a review of three cases. Rev Rhum Engl Ed. 1997;64:59–62. [PubMed] [Google Scholar]
- 16.Horikoshi R, Akimoto T, Meguro D, Saito O, Ando Y, Muto S, et al. Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure. Clin Exp Nephrol. 2011;15:154–158. doi: 10.1007/s10157-010-0362-4. [DOI] [PubMed] [Google Scholar]
- 17.Smack D, Norton SA, Fitzpatrick JE. Proposal for a pathogenesis-based classification of tumoral calcinosis. Int J Dermatol. 1996;35:265–71. doi: 10.1111/j.1365-4362.1996.tb02999.x. [DOI] [PubMed] [Google Scholar]
- 18.Hershkovitz D, Gross Y, Nahum S, Yehezkel S, Sarig O, Uitto J, et al. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J Invest Dermatol. 2011;131:662–9. doi: 10.1038/jid.2010.387. doi: 10.1038/jid.2010.387. Epub 2010 Dec 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet. 2004;36:579–81. doi: 10.1038/ng1358. Epub 2004 May 9. [DOI] [PubMed] [Google Scholar]
- 20.Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet. 2005;14:385–90. doi: 10.1093/hmg/ddi034. Epub 2004 Dec 8. [DOI] [PubMed] [Google Scholar]
- 21.Geirnaerdt MJ, Kroon HM, van der Heul RO, Herfkens HF. Tumoral calcinosis. Skeletal Radiol. 1995;24:148–51. doi: 10.1007/BF00198081. [DOI] [PubMed] [Google Scholar]
- 22.Lai LA, Hsiao MY, Wu CH, Wang TG, Özçakar L. Big Gain, No Pain: Tumoral Calcinosis. AM J Med. 2018;131(1):45–47. doi: 10.1016/j.amjmed.2017.09.003. doi: 10.1016/j.amjmed.2017.09.003. Epub 2017 Sep 15. [DOI] [PubMed] [Google Scholar]
- 23.Huang YT, Chen CY, Yang CM, Yao MS, Chan WP. Tumoral calcinosis-like metastatic calcification in a patient on renal dialysis. Clin Imaging. 2006 Jan Feb;30(1):66–8. doi: 10.1016/j.clinimag.2005.06.024. [DOI] [PubMed] [Google Scholar]
- 24.Catalano O, Alfageme Roldán F, Varelli C, Bard R, Corvino A, Wortsman X. Skin cancer. Findings and role of high-resolution ultrasound. J Ultrasound. 2019 doi: 10.1007/s40477-019-00379-0. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Corvino A, Sandomenico F, Corvino F, Campanino MR, Verde F, Giurazza F, Catalano O. Utility of gel stand-off pad in the detection of Doppler signal on focal nodular lesions of the skin. J Ultrasound. 2019 doi: 10.1007/s40477-019-00376-3. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Corvino A, Corvino F, Catalano O, Sandomenico F, Petrillo A. The Tail and the String Sign: New Sonographic Features of Subcutaneous Melanoma Metastasis. Ultrasound Med Biol. 2017;43(1):370–374. doi: 10.1016/j.ultrasmedbio.2016.09.008. doi: 10.1016/j.ultrasmedbio.2016.09.008. Epub 2016 Oct 12. [DOI] [PubMed] [Google Scholar]
- 27.Barnacle AM, Gower PE, Mitchell AW. Ultrasonography of acute and chronic tumoral calcinosis. Clin Radiol. 2002;57(2):146–9. doi: 10.1053/crad.2001.0726. [DOI] [PubMed] [Google Scholar]
- 28.Chakarun CJ, Talkin B, White EA, Romero M, Ralls PW. Tumoral calcinosis: sonographic sedimentation sign. J Clin Ultrasound. 2011;39(6):367–70. doi: 10.1002/jcu.20793. doi: 10.1002/jcu.20793. Epub 2011 Feb 18. [DOI] [PubMed] [Google Scholar]
- 29.Neeman Z, Wood BJ. Angiographic findings in tumoral calcinosis. Clin Imaging. 2003 May Jun;27(3):184–6. doi: 10.1016/s0899-7071(02)00523-5. [DOI] [PubMed] [Google Scholar]
- 30.Corvino F, Giurazza F, Cangiano G, Silvestre M, Cavaglià E, de Magistris G, Amodio F, Corvino A, Niola R. Endovascular treatment of peripheral vascular blowout syndrome in end-stage malignancies. Ann Vasc Surg. 2019 doi: 10.1016/j.avsg.2018.10.051. pii: S0890-5096(19)30074-3. doi: 10.1016/j.avsg.2018.10.051. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
- 31.Corvino F, Silvestre M, Cervo A, Giurazza F, Corvino A, Maglione F. Endovascular occlusion of pulmonary arteriovenous malformations with the ArtVentive Endoluminal Occlusion System™. Diagn Interv Radiol. 2016;22(5):463–5. doi: 10.5152/dir.2016.15620. doi: 10.5152/dir.2016.15620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Cangiano G, Corvino F, Giurazza F, Silvestre M, Amodio F, Corvino A, Niola R. Endovascular Treatment of Simultaneous Iliac and Superficial Femoral Arterial Pseudoaneurysms After Stenting Procedure Complications. Vasc Endovascular Surg. 2019;53(2):160–164. doi: 10.1177/1538574418805588. doi: 10.1177/1538574418805588. Epub 2018 Oct 9. [DOI] [PubMed] [Google Scholar]
- 33.Corvino F, Giurazza F, Cangiano G, Cavaglià E, Amodio F, De Magistris G, Corvino A, Niola R. Safety and effectiveness of transcatheter embolization in the treatment of internal mammary artery injuries. Radiol Med. 2018;123(5):369–377. doi: 10.1007/s11547-017-0844-5. doi: 10.1007/s11547-017-0844-5. Epub 2017 Dec 18. [DOI] [PubMed] [Google Scholar]
- 34.Corvino A, Catalano O, Corvino F, Sandomenico F, Setola SV, Petrillo A. Superficial temporal artery pseudoaneurysm: what is the role of ultrasound. J Ultrasound. 2016;19(3):197–201. doi: 10.1007/s40477-016-0211-8. doi: 10.1007/s40477-016-0211-8. eCollection 2016 Sep. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Pellino G, Candilio G, De Fatico GS, Marcellinaro R, Piccione A, Cautiero R, Capozzolo A, Guerniero R, Volpicelli A, Reginelli A, Corvino A, Sciaudone G, Canonico S, Selvaggi F. Vascular anomalies of the large bowel. Int Angiol. 2015;34(6 Suppl 1):23–7. [PubMed] [Google Scholar]
- 36.Martinez S, Vogler JB 3rd, Harrelson JM, Lyles KW. Imaging of tumoral calcinosis: new observations. Radiology. 1990 Jan;174(1):215–22. doi: 10.1148/radiology.174.1.2294551. [DOI] [PubMed] [Google Scholar]
- 37.Pakasa NM, Kalengayi RM. Tumoral calcinosis: a clinicopathological study of 111 cases with emphasis on the earliest changes. Histopathology. 1997 Jul;31(1):18–24. doi: 10.1046/j.1365-2559.1997.6050831.x. [DOI] [PubMed] [Google Scholar]
- 38.Corvino A, Catalano O, Setola SV, Sandomenico F, Corvino F, Petrillo A. Contrast-enhanced ultrasound in the characterization of complex cystic focal liver lesions. Ultrasound Med Biol. 2015;41(5):1301–10. doi: 10.1016/j.ultrasmedbio.2014.12.667. doi: 10.1016/j.ultrasmedbio.2014.12.667. Epub 2015 Feb 7. [DOI] [PubMed] [Google Scholar]
- 39.Corvino A, Catalano O, Corvino F, Petrillo A. Rectal melanoma presenting as a solitary complex cystic liver lesion: role of contrast-specific low-MI real-time ultrasound imaging. J Ultrasound. 2015;19(2):135–9. doi: 10.1007/s40477-015-0182-1. doi: 10.1007/s40477-015-0182-1. eCollection 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Corvino A, Catalano O, Corvino F, Sandomenico F, Petrillo A. Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions. AJR Am J Roentgenol. 2017;209(3):W119–W127. doi: 10.2214/AJR.16.17062. doi: 10.2214/AJR.16.17062. Epub 2017 Jun 22. [DOI] [PubMed] [Google Scholar]
- 41.Guarino B, Catalano O, Corvino A, Corvino F, Amore A, Petrillo A. Hepatic inflammatory pseudotumor: educational value of an incorrect diagnosis at contrast-enhanced ultrasound. J Med Ultrason. 2015;42(4):547–52. doi: 10.1007/s10396-015-0624-6. doi: 10.1007/s10396-015-0624-6. Epub 2015 Mar 27. [DOI] [PubMed] [Google Scholar]
- 42.Corvino A, Corvino F, Radice L, Catalano O. Synchronous mucinous colonic adenocarcinoma and multiple small intestinal adenocarcinomas: report of a case and review of literature. Clin Imaging. 2015;39:538–42. doi: 10.1016/j.clinimag.2014.12.019. doi: 10.1016/j.clinimag.2014.12.019. Epub 2015 Jan 7. [DOI] [PubMed] [Google Scholar]
- 43.Corvino F, Centore L, Soreca E, Corvino A, Farbo V, Bencivenga A. Percutaneous “Y” biliary stent placement in palliative treatment of type 4 malignant hilar stricture. J Gastrointest Oncol. 2016;7(2):255–61. doi: 10.3978/j.issn.2078-6891.2015.069. doi: 10.3978/j.issn.2078-6891.2015.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Maurea S, Corvino A, Imbriaco M, Avitabile G, Mainenti P, Camera L, et al. Simultaneous non-functioning neuroendocrine carcinoma of the pancreas and extra-hepatic cholangiocarcinoma. A case of early diagnosis and favorable post-surgical outcome. JOP. 2011;12:255–8. [PubMed] [Google Scholar]
- 45.Campanile F, Maurea S, Mainenti P, Corvino A, Imbriaco M. Duodenal involvement by breast cancer. Breast J. 2012;18(6):615–6. doi: 10.1111/tbj.12034. doi: 10.1111/tbj.12034. Epub 2012 Oct 30. [DOI] [PubMed] [Google Scholar]
- 46.Marie I, Duparc F, Janvresse A, Levesque H, Courtois H. Tumoral calcinosis in systemic sclerosis. Clin Exp Rheumatol. 2004;22:269. [PubMed] [Google Scholar]
- 47.Laswad T, Alamo L, Hofer M, Rotman S, Gudinchet F. Tumoral calcinosis in a child: a case report and review. Praxis. 2009;98:23–28. doi: 10.1024/1661-8157.98.1.23. [DOI] [PubMed] [Google Scholar]
- 48.Jones BC, Sundaram M, Kransdorf MJ. Synovial sarcoma: MR imaging findings in 34 patients. AJR. 1993;16:827–830. doi: 10.2214/ajr.161.4.8396848. [DOI] [PubMed] [Google Scholar]
- 49.Janssen MCH, de Sévaux RGL. Tumoral calcinosis. J Inherit Metab Dis. 2010;33:91–92. doi: 10.1007/s10545-009-9019-4. [DOI] [PMC free article] [PubMed] [Google Scholar]